Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 9,831 shares at $52.35 ($515K) on 2020-10-01, disclosed to the SEC on 2020-10-02.
Open-market sale of $515k EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.00 | 100 | $5K | 1.0% |
| 2 | $52.08 | 69 | $4K | 0.7% |
| 3 | $52.35 | 4,831 | $253K | 49.1% |
| 4 | $52.35 | 4,831 | $253K | 49.1% |
| Total | $52.34 avg | 9,831 | $515K | 100% |
| Filing → |
| EIDX | SELL | 2020-10-30 | $456K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |
| EIDX | SELL | 2019-09-27 | $96K | — | Filing → |